San Mateo, CA, United States of America

Andrei Chtchemelinine

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 16.2

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovations of Andrei Chtchemelinine

Introduction

Andrei Chtchemelinine is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of cancer research, particularly through his work on Cot inhibitor compounds. With a total of 3 patents to his name, Chtchemelinine continues to push the boundaries of innovation in his field.

Latest Patents

One of his latest patents is focused on the process for preparing a Cot inhibitor compound. This patent discloses syntheses of a Cot (cancer Osaka thyroid) inhibitor, which has a specific formula aimed at combating cancer. His work in this area showcases his commitment to developing effective treatments for serious health conditions.

Career Highlights

Chtchemelinine is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to medical science.

Collaborations

Some of his notable coworkers include Andrew C Stevens and Kevin M Allan. Their collaboration fosters a dynamic environment for innovation and research, leading to advancements in cancer treatment.

Conclusion

Andrei Chtchemelinine's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a dedication to improving health outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…